TY - JOUR
T1 - Correction to
T2 - White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab (Journal of Neuro-Oncology, (2019), 145, 3, (461-466), 10.1007/s11060-019-03279-9)
AU - Estephan, Fayez
AU - Ye, Xiaobu
AU - Dzaye, Omar
AU - Wagner-Johnston, Nina
AU - Swinnen, Lode
AU - Gladstone, Douglas E.
AU - Ambinder, Rich
AU - Kamson, David Olayinka
AU - Lambrecht, Sebastian
AU - Grossman, Stuart A.
AU - Lin, Doris D.M.
AU - Holdhoff, Matthias
N1 - Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2019/12/1
Y1 - 2019/12/1
N2 - The following discrepancies and errors were found in the original publication.
AB - The following discrepancies and errors were found in the original publication.
UR - http://www.scopus.com/inward/record.url?scp=85075466611&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075466611&partnerID=8YFLogxK
U2 - 10.1007/s11060-019-03346-1
DO - 10.1007/s11060-019-03346-1
M3 - Comment/debate
C2 - 31758486
AN - SCOPUS:85075466611
SN - 0167-594X
VL - 145
SP - 467
JO - Journal of neuro-oncology
JF - Journal of neuro-oncology
IS - 3
ER -